Pharmacologic management of patients with both heart failure and diabetes.
Diabetes and heart failure often occur together in patients, with each condition influencing the treatment of the other. Each disease has its own well-documented impact on prognosis, but when they are present in the same patient, the risk of morbidity and mortality increases substantially. Some therapies used in the treatment of diabetes are contraindicated in patients with heart failure, and some therapies for treating heart failure are often mistakenly believed to be contraindicated in patients with diabetes. This article aims to clarify the evidence behind treating these conditions simultaneously and dispel the myths surrounding the pharmacologic management of diabetes in heart failure and vice versa.
MacDonald
Michael R
MR
Department of Cardiology, Hairmyres Hospital, Eaglesham Road, East Kilbride, Glasgow G75 8RG, Scotland, United Kingdom. michael.macdonald@nhs.net
Petrie
Mark C
MC
Fisher
Miles
M
McMurray
John J V
JJ
D001786:Blood Glucose; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D003920:Diabetes Mellitus / Q000188:drug therapy*; D003925:Diabetic Angiopathies / Q000188:drug therapy*; D006333:Heart Failure / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*
D001786:Blood Glucose; D002317:Cardiovascular Agents; D007004:Hypoglycemic Agents